The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Brinzolamide Sandoz 10mg/ml eye drops, suspension



Rowex LtdPA0711/226/001

Main Information

Trade NameBrinzolamide Sandoz 10mg/ml eye drops, suspension
Active SubstancesBrinzolamide
Dosage FormEye drops, suspension
Licence HolderRowex Ltd
Licence NumberPA0711/226/001

Group Information

ATC CodeS01EC Carbonic anhydrase inhibitors
S01EC04 brinzolamide

Status

License statusAuthorised
Licence Issued04/07/2014
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back